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Summary A series of 21 phenotypically characterised T-cell lymphomas histologically defined as lympho-
cytic, lymphoblastic, immunoblastic, AILD type, pleomorphic, T-zone and Lennert's T-cell lymphoma, were
investigated for T-cell receptor (TcR) and immunoglobulin (Ig) gene rearrangements. Phenotypic analyses of
frozen sections and cell suspensions were heterogeneous and in many cases no single T-cell marker recognised
all of the malignant cells. Data derived by staining with antibodies reactive with antigens in paraffin
embedded tissue were consistent with T NHL in all cases except lymphoblastic lymphoma. TcR gene
rearrangements were observed in lymphocytic, lymphoblastic and immunoblastic lymphoma, however, in the
remaining 14 phenotypically and histologically defined peripheral T-cell lymphomas, 2 showed rearrangement
of TcRy and fl genes consistent with T NHL and 2 showed Ig JH rearrangements only, suggestive of either
reactive T-cell populations masking cryptic disease or presence of tumour populations with aberrant gene
rearrangement and expression of T lineage antigens. No Ig or TcR gene rearrangements were found in the
remaining 10 cases, in which morphologically identifiable tumour cells comprised 10-90% of the cell
population. In 3/6 cases tested some CD3 positive cells failed to stain with WT31 or ,BF1, monoclonal
antibodies that recognise determinants on combined TcRy/3 or TcRfl chains respectively. Whether these cases
represent tumours arising from an undetermined cell of origin or polyclonal expansions of T-cells remains to
be determined. Our results confirm the phenotypic heterogeneity of histologically defined peripheral T-cell
lymphoma and indicate that in these particular histological subtypes gene rearrangement analysis can also
yield heterogeneous results which may be unhelpful in determining cell lineage and clonality.
Phenotypic analyses have been widely used for the
characterization of non-Hodgkin's lymphoma (NHL) and
this approach has been most widely applied in NHL of B-
cell origin (B-NHL) where surface phenotype can be closely
correlated with the normal maturation pathway of immuno-
globulin (Ig) producing lymphocytes (Stein et al., 1980). The
situation with NHL of T-cell lineage (T-NHL) is less clear.
Whilst T-cell chronic lymphocytic leukaemia (T-CLL), myco-
sis fungoides and sezary syndrome regularly show a pheno-
type consistent with peripheral T-cells (Stein et al. 1984), the
node-based T-NHL display great phenotypic heterogeneity
(Jones et al., 1986) and often represent a diagnostic diffi-
culty. This is compounded by the absence of an immuno-
cytochemical marker of monoclonality within the T-cell
system (Wright, 1986). Analysis of T-cell receptor (TcR)
gene rearrangement by Southern blot hybridization has
become of considerable diagnostic importance in these diffi-
cult cases by providing evidence of clonality and of T-cell
lineage. In this regard a number of investigators have found
that the majority of T-cell leukaemias and lymphomas show
T-cell receptor gene rearrangements (O'Connor et al., 1985;
Minden & Mak, 1986; Knowles, 1986; Pelicci et al., 1985;
Ramsey et al., 1987). This has not been our experience in
peripheral T-cell lymphomas.
Peripheral T-cell lymphomas represent a diverse histo-
logical group of neoplasms and heterogeneous phenotypes
often with an admixture of cell types that make it difficult to
recognize the neoplastic cell population (reviewed in Suchi et
al., 1987). In this study we report the results of an immuno-
phenotypic and genotypic analysis of 17 cases of node based
peripheral T-NHL, histologically characterised as histologies
of AILD type, pleomorphic, T zone, Lennert's lymphoma,
lymphocytic and immunoblastic lymphoma. These data are
presented with findings on 4 cases of lymphoblastic lym-
phoma. Our results confirm that cases of peripheral T-NHL
are markedly-heterogeneous in phenotype and indicate that
in histological subtypes other than lymphocytic and
immunoblastic, TcR gene rearrangements are not always
clonal. These data suggest that investigations of gene re-
arrangement within this group of tumours may often be
unhelpful in establishing cell lineage and clonality.
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Materials and methods
Tissue
Lymphoma tissue was obtained fresh from diagnostic lymph
node biopsy specimens. Each specimen was subdivided and
tissue taken for cell suspension preparation, histopatho-
logical diagnosis and for frozen section study. Lymphocytes
were isolated from tissue by standard methods (Stevenson et
al., 1983) and the viability of the recovered cells was always
greater than 95% by trypan blue exclusion. Lymphomas
entered into this study were selected on the basis of their
histological subtype and were drawn from a large series of
lymphomas studied at Southampton (Smith et al., 1988).
Phenotypic studies
Phenotypic analyses were carried out on tissue sections and
cell preparations using a panel of antibodies. Ig was demon-
strated using rabbit anti-Ig heavy and light chain reagents
(Dako) or with monoclonal antibodies (mabs) to k and A
light chains. Lineage and subset markers were identified
using the appropriate mabs identified by their workshop
cluster numbers (Leucocyte Typing III, Oxford University
Press, 1987) and detected by the corresponding mabs given
in brackets, these included: CDI (OKT6), CD2 (OKT11),
CD3 (UCHT1, OKT3), CD4 (OKT4), CD5 (OKT1), CD7
(HB2), CD8 (OKT8), CD22 (SCHL1), CD37 (WR17) and
CD38 (OKT1O). WR18, a mab recognising HLA DP, DQ
and DR determinants, was also used (Stevenson et al., 1986).
Biopsy cell suspensions from five cases were stained with
the mab WT31 which recognises the TcR a: chains on the
surface of T-cells (Spits et al., 1985). Frozen biopsy sections
from 3 cases were stained with WT31 and ,BFl, a mab which
recognises a framework determinant on the TcRf chain
(Brenner et al., 1987).
Cell suspensions were stained by indirect immuno-
fluorescence; cytocentrifuge preparations were stained by
indirect immunoperoxidase by methods previously described
(Stevenson et al., 1983). Immunohistochemical staining of
frozen tissue was performed using a modification of the
method of Stein et al. (1984). Briefly, 6pm cryostat sections
were dried at room temperature and stored at -20°C over
dessicant until stained. On the day of staining sections were
fixed in dry acetone for 15 min at room temperature and
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washed in Tris buffered saline, pH 7.6 (TBS). Mabs were
then incubated with the sections for 30min which were then
washed twice in TBS. Peroxidase conjugated rabbit anti-
mouse Ig (Dako, diluted 1/80 in TBS) was then applied for a
further 30min and the sections again washed.
Immunoperoxidase staining of paraffin embedded material
was performed on 4pm sections using PAP or ABC com-
plexes as previously described. Endogenous peroxidase
activity was inhibited using 0.5% H202 in methanol for
10min. The sections were pre-digested where necessary using
0.1% trypsin in 0.1% calcium chloride solution at 37°C.
(Stevenson et al., 1983). All first layer staining reactions were
incubated overnight at 4°C and appropriate controls per-
formed for antibody specificity and titre. The following
antibodies were used to stain paraffin sections: UCHLI and
MT1 (T-cell specific), MB2, 4KB5 (B-cell specific) and BER
H2 (CD30 activated cells) (Poppema et al., 1987; Smith et
al., 1986). For both paraffin and frozen sections peroxidase
methods the final reaction product was developed using 3.3
diaminobenzidine tetrahydrochloride (DAB).
Genotypic studies
High molecular weight DNA was extracted from frozen
biopsy specimens or cell suspensions by routine methods
(Bidwell & Jarrold, 1986) and 10jg aliquots digested with
50 units of appropriate restriction endonucleases under con-
ditions specified, DNA fragments were size-separated in
0.7% agarose gels and transferred to nylon (hybond-N)
filters according to the method of Southern (1975). These
filters were prehybridised in 6 x SSC, 0.5% SDS, 5 x Den-
hart's solution and 6% PEG 8,000 containing heterologous
fragmented salmon sperm DNA at 65°C overnight, followed
by hybridisation at 65°C overnight in the same solution
containing, added 32P-labelled gene probe. Filters were sub-
sequently washed under stringent conditions (Bidwell &
Jarrold, 1986) and hybridizing bands visualized by auto-
radiography for 3-10 days at -700C, using Fuji-RX film.
Following autoradiography, probe was removed from filters
by washing with 0.4M NaOH at 450 for 30min followed by
0.1 x SSC, 0.1% SDS, 0.2M Tris-HCI pH 7.5 at 450 for a
further 30min. Filters were then sequentially rehybridized
with further gene probes.
The probes used in this study were an Ig heavy chain
joining region JH probe (C76 R51A - Flanagan & Rabbitts,
1982), an Igk chain constant region probe (pUCR17 -
Foroni et al., 1984) an IgA constant region probe (CHR22)S
8cA - Rabbitts & Forster, 1983), a TcR,B chain gene probe
(Jurkat 2 - Yanagi et al., 1984) and a TcRy gene probe (Le
Franc & Rabbitts, 1985).
Each DNA preparation was digested with 3 different
restriction enzymes - Bam HI, Eco RI and Hind III. All
digests were analysed with the TcR,B probe. The TcRy and
JH probes were used to investigate at least two restriction
digests per preparation, whilst the Ck probe was used in
conjunction with Bam HI digests and CA with EcoRI digests.
In addition, DNA from 7 cases was digested with the
restriction enzyme KpnI and probed with the TcRy gene
probe.
DNA probes were prepared by plasmid amplification in
bacterial host stains. Probe gene inserts were excised from
low gelling temperature agarose gels following appropriate
endonuclease restriction and radiolabelled with a-32P-d CTP
by the random hexanucleotide primer method (Feinberg &
Vogelstein, 1984). In some experiments a TcR,B gene probe
of very high specific activity was produced by labelling with
two radionucleotides instead of one (ax-32P-dATP and
a-32P-dATP).
The sensitivity of the TcRy and fB chain gene probing was
assessed by dilution of DNA isolated from a T-cell immuno-
blastic lymphoma (PB) with germline DNA isolated from a
fresh carcinoma biopsy followed by Southern hybridization.
The sensitivity of the JH and Ck immunoglobulin gene
probing was similarly assessed by dilution of DNA isolated
from a lymphoid cell suspension containing >99% surface
immunoglobulin Mk positive cells prepared from the blood
of a patient with B-cell chronic lymphocytic leukaemia.
Results
Histology and immunophenotype
Fourteen cases of morphologically defined T-cell NHL
entered into the study were given given the following
diagnoses based on initial histology: AILD type (WM, RH),
pleomorphic T-cell (large type) (RR), pleomorphic T-cell
(medium type) (NC), T zone (TD, GS, DC, BM, ET, GB,
JR, TC, AC) and Lennert's NHL (RMc). Seven cases of
phenotypically defined T-cell lymphoma of the following
histologies, lymphoblastic (RQ, KM, PSh, KW), immuno-
blastic (PS, PB) and lymphocytic (WS) were also studied. In
all biopsies the percentage of neoplastic cells was assessed
morphologically on paraffin embedded material stained with
haematoxilin and eosin (H and E). Phenotypic characterisa-
tion was performed in cell suspension and in frozen and
paraffin sections. The results of frozen section and cell
suspension analyses were closely concordant and in 18 cases
the data were consistent with T-NHL: in the remaining three
cases (ET, JR, RMc) the lineage of the neoplastic cell
population could not be determined unequivocally from
these data. Data derived from paraffin sections were consis-
tent with T-NHL in 17 cases; in the remaining 4 cases,
neoplastic cell staining was observed with UCHL1 and MB2
in case NC and with MB2 in cases RQ, KM and PSh. All
neoplastic cells in preparations were Ig negative and failed to
stain with B-cell antibodies identifying CD22 and CD37 pan
B-cell antigens. A summary of the phenotypic data is given
in Table I and two cases are illustrated, WM (AILD type) in
Figure 1 and DC (T zone) in Figure 2.
In the data presented in Table I, atypical neoplastic cells
from 10 cases in frozen tissue sections and in cell pre-
parations were either variably stained (WM, RH, TD, BM,
NC, RR, PS) or were negative (AC, PB, PSh) for CD3. The
CD3 negative cells were cytoplasmic CD3 negative on stain-
ing of frozen sections and cytocentrifuge preparations. This
variability was less evident with CD2 but CD7 was variably
expressed in 2 cases (WM, TD) and was absent in 4 cases
(AC, NC, RR, PS). Not all cases were stained with CD4 and
CD8 antibodies, however CD8 was present in 3 cases in the
absence of CD4 (RH, GB, TC) and CD4 was present in the
absence of CD8 in 4 cases (DC, WS, RQ, KM). Neoplastic
cells from 5 cases did not express CD4 or CD8. Cells from 8
cases expressed HLA class II antigens (Table I).
Cell suspensions from 5 cases (WM, DC, ET, GB and
NC) were stained with the mab WT31 which recognises TcR
a4 chains on the surface of T-cells. (Spits et al., 1985). In 3
cases staining with CD3 and WT31 was in agreement,
however in 2 (DC and ET) WT31 failed to stain 22% and
15% of the CD3+ cells in the preparations respectively (CD3
stained 77% and 49% of cells in DC and ET preparations
respectively). WT31 and ,BF1 mabs were used to stain frozen
biopsy sections from DC, TD and RMc. In DC WT31 and
fiF1 stained fewer cells than those positive for CD3. In RMc
the number of CD3, WT31 and ,BFl were similar. In TD the
number of CD3 and ,BFI positive cells were similar and
greater than the number of cells stained by the mab WT31.
Gene rearrangements
The sensitivity of the TcRy and ,B chain gene probing was
investigated by dilution of tumour DNA from case PB
(immunoblastic lymphoma) with germline DNA. TcRy and P
gene rearrangements were readily detectable when tumour
DNA represented 3% of the total DNA analysed. The TcRf
probing is illustrated in Figure 3. Similarly JH and Ck Ig
gene rearrangements were detectable at dilutions of 3% of B-
cell tumour DNA with germline DNA. The four cases of THETEROGENEITY OF T-CELL LYMPHOMA 725
Table I Neoplastic cell phenotype
Histology
AILD type
T zone
Lennert's
Neoplastic
Case cells %
WM
RH
TD
GS
DC
BM
ET
GB
JR
TC
AC
RMc
40
30
30
70
30
30
60b
50
50b
50
50
Frozen section/cell suspensionsa
CD] CD2 CD3 CD4 CD5 CD7 CD8
+ +
_+
(+)
(+)
(+)
+
+ +
(+)
+
+ (+) (+)
_ + +
+ -
+ + +
+
HLA
CD38 class II UCHLI
+ + + +
+ + +
+ (+) -+ + + - - -
+ - - + +
+ + - + - + + + _ _
+ + - + +
(+) + - - -
+ + + - + + + _ _ _
+ + - _ _
+ + + + + + +
+ - - + + + - _ _
+ + - _ _
Pleomorphic medium NC
Pleomorphic large
Immunoblastic
Lymphocytic
Lymphoblastic
RR
PS
PB
WS
RQ
KM
PSh
KW
90 (+) (±) (+)
10 + (+)
80 (+) + (+)
98 - + -
90
85
90
80
50
+ + +
+
+ + +
+ +
+ +
+ + +
+ (+) + +
+ + (+) + +
+ -
+
+ +
- - + +
+ + + + + - _ _
+
Blanks in table refer to tests not done. a+ positive. (+) variable staining on tumour cell population, -negative. All neoplastic cells were
negative for Ig, CD22 and CD37. % of neoplastic cells in biopsies on sections of paraffin embedded tissue stained with H and E. bNeoplastic
cell phenotype could not be adequately defined on frozen section or in cell suspension.
..
*..
.'s
*f¢ ....V
,#
Figure 1 (a-UCHLI, b-MT1) WM (T-Cell Receptor Gene
Rearranged): Sections of this case stained with paraffin reactive
T-cell antibodies, UCHL1 and MTI. There is extensive staining
of the tumour population with many morphologically identifiable
tumour cells staining.
Figure 2 (a-UCHLI, b-MTI) DC (T-Cell Receptor Germline):
The T-cell directed antibodies, UCHL1 and MTI, stain the bulk
of the infiltrating cells in this lymph node biopsy. Large,
morphologically identifiable tumour cells are positive with both
reagents. This appearance in paraffin is consistent with T-cell
lymphoma.
Paraffin sectionsa
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15.0 Kb--- b
12.5 Kb-.'
6.5 Kb-
3.5 Kb
R
100 20 10 5 3 1 0
% Rearranged DNA
Figure 3 DNA was isolated from lymph node biopsy PB
(immunoblastic lymphoma) and diluted with germline DNA
isolated from a carcinoma. DNA was digested with Hind III and
probed with a 32P labelled TcR,B probe as described in the
methods. Germline bands of 6.5 and 3.5 kb were detected,
reflecting complete DNA digestion by Hind III. No 8.0kb band,
which results from partial cutting at one Hind III site, was seen
(Furley et al., 1986). The rearranged band is detectable at 3%
dilution of tumour DNA.
Table II Genotype of peripheral T lymphomas
Gene rearrangementa
TcR Ig
Histology
AILD type
T zone
Pleomorphic medium
Pleomorphic large
Lennert's
Immunoblastic
Lymphocytic
Lymphoblastic
Caseb
WM
RH
TD
GS
DC, BM, ET
GB, JR, TC
AC
NC
RR
RMc
PS
PB
WS
RQ
KM
PSh
KW
Y /3 JH Ck CA
R
G
R
G
G
G
G
G
R
G
R
G
G
G
G
G
R R
R R
R
R
R
R
R
R
R
R
R
G
R
R
R
G
G
G
G
G
G
G
G
R
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
Blanks in table refer to tests not done. aR clonal rearrange-
ment; G germline configuration. bDNA for analysis was isolated
from frozen biopsy tissue from cases WM, RH, TD, GS, DC,
JR, RMc, NC, RR, KM, PS, PB & WS. Remaining cases BM,
ET, GB, TC, AC, RQ, PSh & KW DNA was isolated from cell
suspensions prepared from fresh biopsy tissue.
lymphoblastic lymphoma all showed TcRy and # gene
rearrangement, in addition one of the cases (KM) also show
JH gene rearrangement. In these cases the percentage of
tumour cells varied from 50-90% (Table II).
Southern hybridization analyses of the peripheral T-cell
lymphomas revealed TcR gene rearrangements in the
lymphocytic (WS), immunoblastic lymphomas (PS, PB) and
C PS PSh KW WM DC
Bam Hi
Figure 4 DNA was isolated from lymph node biopsies from PS
(immunoblastic lymphoma) PSh, KW (T lymphoblastic lym-
phoma) WM (AILD lymphoma) and DC (T zone lymphoma).
Control DNA was isolated from a lymph node biopsy involved
with carcinoma. DNA was digested with the restriction enzyme
Bam Hl and probed with a 32P-labelled TcRy probe as described
in Materials and methods. Rearranged bands are present in PS,
PSh, KW and WM. Only the germline bands at 15 and 12.5kb
were recognised in DC.
in one case of AILD type (WM) and in one case of T zone
NHL (TD) (Table II); TD also showed JH gene rearrange-
ment. A further two cases (RH, GS) showed JH gene
rearrangements only. The remaining 10 cases showed no
detectable TcR or Ig gene rearrangements. These data are
summarized in Table II. Representative data are shown in
Figures 4-6.
TcRf gene probing with probe labelled with two nucleo-
tides (see Materials and methods) was carried out on DNA
from 4 patients but failed to reveal TcR,B gene rearrange-
ments in RR, GS, DC or ET. Kpn 1 enzyme digests were
completed on DNA from RR, PS, DC, TD, ET, TC and
RMc and analysed with the TcRy gene probe. TcRy gene
rearrangements were confirmed in PS and TD but were not
seen in the other cases tested.
Discussion
T-NHL is often associated with a characteristic histological
picture. However, the association is not absolute and a firm
diagnosis often requires phenotypic confirmation (Wright,
1986). All the cases of lymphoblastic, immunoblastic and
lymphocytic lymphoma were shown to be of T-cell pheno-
type by the expression of one or more pan T-cell antigens.
Eleven of the 14 cases presented in this communication and
considered to be of T-cell origin on morphological criteria
alone, demonstrated a phenotypic pattern consistent with a
diagnosis of T-NHL when examined with monoclonal anti-
bodies recognising the T-cell lineage associated markers,
CD2, CD3 and CD7. In the remaining 3 cases the precise
surface phenotype of the tumour cells could not be deter-
mined in cell suspension or in frozen section. In paraffin
section the antibodies MTI and/or UCHLI stained tumour
cells in 18 cases including all cases of peripheral T-cell
lymphoma; MB2 stained tumour cells in three cases of
lymphoblastic (RQ, KM, PSh) and in one case (NC) of
pleomorphic lymphoma, these data are consistent with pub-
lished findings which report that staining with these anti-
bodies is not an absolute marker for the T- or B-cell lineage
(Poppema et al., 1987).
Phenotypic variation is a common feature amongst T-cell
lymphomas and whilst leukaemias derived from early T-cells
may display consistent phenotypic features (Greaves, 1981)
the general picture for node based T-cell lymphoma is one of
heterogeneity (Jones et al., 1986). An additional complica-HETEROGENEITY OF T-CELL LYMPHOMA 727
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Barn HI Eco RI Hind III
Figure 5 DNA was isolated from lymph node biopsies from KM, WM and DC as described in Figure 1 and digested with the
restriction enzymes Bam HI, Eco RI and Hind III and probed with a 32P-labelled TcRJB probe as described in Materials and
methods. Rearranged bands are present in KW and WM. Only the germline bands 24kb (Bam HI), 11.5kb and 4.0kb (EcoRl)
and 8kb, 6.5kb and 3.5kb (Hind III) were recognised in DC.
18 Kb-O' 7.5 Kb
C KM DC
Eco RI
Figure 6 DNA was isolated from lymph node
KM (lymphoblastic lymphoma) and GS and D(
phoma). DNA was digested with the restriction
and Hind III and probed with a 32P-labelle4
described in Materials and methods. Rearran
present in KM and GS. Only the germline band,
and 7.5kb (Hind III) were recognised in DC.
tion in the diagnosis of node based T-NHL
tumour cells present within the biopsy T-cell
are weakly expressed or absent (Warnke &
Furthermore many cases may lack T subset n
to express a phenotype representative of peri]
cells (Knowles & Halper, 1982; Grogan et al.
al., 1986). The finding that tumour cells fro
cases of T-NHL described in this report lac
pan T-cell antigens and/or fail to express su
consistent with these published data. In thes
negative tumour cells were both cytoplasn
antigen negative and were not representative
CD3 positive populations observed in T-cell
-
(Campana et al., 1987). Many of the cases
expressed HLA class II antigens consistent wi
(Doggett et al., 1984; Borowitz et al., 198.
1986). Whether this finding represents aci
tumour cell population by accessory cells wi
(Brown et al., 1984) or binding of shed
products, was not determined.
We feel that the phenotypic heterogeneity
in T-cell lymphoma (Jones et al., 1986) is rel
part, to aberrant gene expression by malignant cells. In this
respect, Winberg et al. (1985) have demonstrated progressive
loss of T-cell antigens in a single case of T-cell lymphoma in
which multiple, sequential biopsies were available.
There is consensus in the literature that the analysis of Ig
superfamily gene rearrangements can provide evidence of
lymphocyte lineage and B- or T-clonality in human lympho-
reticular tumours of uncertain histogenesis (O'Connor et al.,
1985; Minden & Mak, 1986; Knowles, 1986; Pelicci et al.,
1985; Korsmeyer, 1987). This type of study is considered
particularly valuable in the distinction between neoplastic
and reactive pathologies as phenotypic markers of clonality
are not available for the T-cell lineage (Wright, 1986). The
data we present on peripheral T-NHL therefore require
detailed comment. Of the 14 cases which were considered to
C GS DC be of T-cell lineage by histological and phenotypic criteria,
Hind III only 2 (WM and TD) showed TcR gene rearrangement, TD
e biopsies from also showed JH gene rearrangement which does occur infre-
C (T zone lym- quently in T-cell lymphoma and is not inconsistent with this
enzymes EcoRl diagnosis (Pelicci et al., 1985). A further 2 cases (RH and
d JH probe as GS) showed rearranged JH genes only, confirming the presence
ged bands are of a clonal population of tumour cells. Since JH gene
s 18 kb (EcoR1) rearrangement in the absence of TcR rearrangements are
found in early B-cells (Korsmeyer, 1987) these cases may
represent lymphomas in which the presence of a pleomorphic
but reactive T-cell population masks detection of an underly-
is that on large ing B-cell neoplasm (Arnold et al., 1983). We cannot,
surface antigens however, rule out the presence of a cryptic tumour popula-
Rouse, 1985). tion derived from cells other than B- or T-cells showing both
narkers and fail aberrant gene rearrangements and the expression of T-
pheral blood T- lineage antigens since JH rearrangements have been found in
., 1985; Jones et TDT positive AML (Foa et al., 1987). Parallel expression of
im many of the CD3 and B-cell markers have been described in hairy cell
Ik one or more leukaemia (Haegert & Smith, 1987; Haegert et al., 1986) and
ibset markers is it is clearly possible that these 3 cases may also represent
se studies, CD3 examples of early B-cell tumours aberrantly expressing T-cell
iic and surface markers. It must be noted, however, that these tumours did
of cytoplasmic not express Ig, as was the case with CD3 positive hairy cell
acute leukaemia leukaemia.
3 in this report One possibility considered was that the original diagnoses
ith other studies were incorrect and the histological processes present repre-
5; Jones et al., sented reactive, rather the neoplastic, pathology. However, at
tivation of the follow up 4 cases (GB, ET, TC, AC) have died of dissemi-
ithin the biopsy nated disease and a fifth (DC) has relapsed with extensive
HLA class II cutaneous tumour infiltration consistent with the original
diagnosis of T-NHL. Chromosomal analysis in the case NC
frequently seen demonstrated a neoplastic population carrying the karyo-
ated, at least in typic marker Del (1llq) and 14q +. Whilst the chromosomal
24Kb- 11.5 Kb
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abnormality observed in NC is consistent with the presence
of a neoplastic population, no rearrangements of either TcR
or Ig genes were seen.
We do not feel that relative insensitivity of our Southern
blot technique is responsible for the failure to detect gene
rearrangements. The tumour biopsies investigated in this
series contained histologically recognisable tumour cell infil-
trate to the level of 10-90% of the total cell population. This
is well above the threshold of detection of TcR and Ig gene
rearrangements established by the experiments in this labora-
tory, where DNA from clonal populations diluted with
germline DNA has been detected to a level of 3%. This
sensitivity threshold is in agreement with that demonstrated
by other laboratories for both TcR and Ig genes (Cleary et
al., 1984; Korsmeyer et al., 1987).
While our data suggest polyclonal origin for some of the
neoplastic populations, alternative explanations include (I)
the deletion of TcR genes on one or both chromosomes in
the tumour populations, so that only germline bands repre-
senting either the non-malignant cells in the biopsy or the
non-rearranged allele are seen, or (II) that DNA fragments
from one rearranged allele may comigrate with genes in the
germline configuration. Although these possibilities may
occur on occasion they are unlikely to account for the low
detection rates of monoclonalility in the present T-NHL
series where TcR probes were used to analyse DNA samples
digested separately wityh 3 different restriction enzymes.
Recently, a second T-cell receptor has been identified on
human T-cells. In this case a functional CD3 epitope is
associated with a heterodimer of TcR gamma and delta
chains on the surface (Royer & Reinherz, 1987). These cells
are usually CD4 and CD8 negative and fail to stain with the
mab, WT31, recognising a determinant expressed by com-
bined TcR-alpha and beta chains (Spits et al., 1985). We
have subsequently reinvestigated cell suspensions from 5
cases with the mab WT31. In 3, an equal number of cells
were CD3 and WT31 positive. In 2 cases, however, (ET and
DC), 22% and 15% of cells, respectively, were CD3 positive
and WT31 negative. Thus, in these 2 cases, a proportion of
cells expressed CD3 in the absence of an epitope associated
with surface TcR-alpha/beta chains. This observation was
confirmed in frozen section in the case, DC. Neither ET nor
DC showed TcR-gamma gene rearrangements, when tested
with a range of enzymes. Recently 5 J segments have been
identified in the TcRy locus, JP1, JP and JI located
upstream of the Cyl segment and JP2 and J2 upstream of
the Cy2 segment (Huck & LeFranc, 1987). Rearrangements
involving any of the three JP gene segments cannot be
identified using the enzymes Bam HI, Eco RI and Hind III.
However Kpn 1 digests will identify rearrangements involv-
ing all 5 J gene segments. With this enzyme TcRy rearrange-
ments were confirmed in PS and TD but were not found in
RR, DC, ET and RMc. These populations await further
investigation with appropriate human TcR delta probes.
Discordant expression of CD3 and TcR-beta-chain deter-
minants has recently been described in human lymphoma by
Picker et al. (1987). These authors used immunohisto-
chemical techniques to investigate the parallel expression
CD3 and an antibody, Beta-Fl which identifies a TcR-beta
chain framework determinant (Brenner et al., 1987). Whilst
28 reactive proliferations contained T-cells expressing both
CD3 and Beta-Fl, 29 of 55 lymphomas investigated failed to
demonstrate parallel expression of these 2 determinants. In
33 cases of peripheral T-cell lymphoma 11 demonstrated a
discrepant phenotype, with CD3 in the absence of TcR-beta-
chain determinants representing the majority of these. In T-
lymphoblastic lymphoma a discrepancy was present in 9 of
22 cases.
More recently Weiss et al. (1988) have described similar
findings to those reported in this communication. These
authors report six cases of peripheral T-cell lymphoma that
lack Ig and TcRy and # gene rearrangements. A seventh case
was rearranged for TcRy and JH genes. These T-cell cases,
like those in this report were phenotypically heterogeneous
and expressed HLA class II antigens. In none of these cases
did the tumour cells bind jFl. We have tested this antibody
against three cases in this study. In one case (DC), fF1 and
WT31 failed to stain all CD3 positive cells, however in the
other two (RMc, TD) staining of tissue sections with ,F1
and CD3 was similar. In TD WT31 stained fewer cells than
,BFl suggesting the presence of TcRf chains in the absence
of yfl dimers. These populations await further investigation.
Our data based on immunophenotypic and genotypic
investigations of a T-NHL lymphoma series are suggestive of
either abnormal or aberrant TcR receptor expression in the
neoplastic populations or that these populations are polyclo-
nal. These findings highlight a unique group of histologically
recognisable T-cell lymphomas in which other workers have
also failed to find TcR gene rearrangements in some cases
(O'Connor et al., 1985; Ramsey et al., 1987; Weiss et al.,
1988).
In our series of 322 node based NHL, peripheral T-cell
tumours comprise 6% of all cases and 40% of the T-cell
tumours studied (Smith et al., 1988). Thus, the diagnostic
difficulty presented by the discordant plienotypic and gene
rearrangement data represents a small component of all
lymphomas presenting for diagnosis. It is possible that in a
small number of cases, failure to find TcR gene rearrange-
ments may arise following an incorrect histological diagnosis
but this is unlikely in the presence of detailed phenotypic
analysis of viable and fixed biopsy material. Thus, our data
suggest that within the peripheral T-cell lymphoma group,
gene rearrangement analyses can yield heterogeneous results
which may be unhelpful in establishing cell lineage. Within
this group of tumours, genotypic data must be interpreted
with care and in parallel with immunophenotypic
observations.
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